BCRX Net Income Growth
Biocryst Pharmaceuticals Inc · Net Income Growth
BCRX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-977.18%period ending
BCRX TTM Net Income YoY % (-24.64% → -977.18%)
Year-over-year change
High-resolution chart · PNG
BCRX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -977.1835% | |
| -756.5233% | |
| 396.87% | |
| 92.9097% | |
| 75.5292% | |
| 74.3654% | |
| 60.7657% | |
| 47.6126% | |
| 39.876% | |
| 7.809% | |
| 8.3269% | |
| -22.2364% | |
| -15.7822% | |
| -16.6409% | |
| -34.2569% | |
| 14.7379% | |
| 2.0809% | |
| 7.4105% | |
| -0.6827% | |
| -81.5036% | |
| -83.8945% | |
| -81.4755% | |
| -67.8779% | |
| 6.5546% | |
| 7.3915% | |
| -8.3667% | |
| -7.5505% | |
| -43.212% | |
| -59.3308% | |
| -37.7411% | |
| -53.9205% | |
| -83.9955% | |
| -67.388% | |
| -66.2118% | |
| -19.2913% | |
| 26.2214% | |
| 34.414% | |
| 8.1993% | |
| -28.1852% | |
| -88.1387% | |
| -134.3605% | |
| -0.9379% | |
| 4.8021% | |
| 6.1367% | |
| 19.7561% | |
| -40.5076% | |
| -50.0897% | |
| -8.9947% | |
| -2.0972% | |
| 4.7849% | |
| 22.96% | |
| 13.3139% | |
| 18.5911% | |
| 24.8909% | |
| 31.3754% | |
| 23.6075% | |
| 8.7051% | |
| -12.8459% | |
| -68.2235% | |
| -534.7622% | |
| -509.4629% | |
| -555.6363% | |
| -151.6678% | |
| 54.1319% | |
| 51.105% | |
| 67.7211% | |
| 45.6099% | |
| 50.0275% | |
| 56.7479% | |
| 37.2142% | |
| 14.8817% | |
| -0.7161% | |
| 5.7101% | |
| 25.2067% | |
| 33.3862% | |
| 9.5925% | |
| -26.4568% | |
| -57.2601% | |
| -67.1261% | |
| -68.1123% | |
| -49.7879% | |
| -33.1123% | |
| -23.6667% | |
| -27.0764% | |
| -27.3613% | |
| -38.4708% | |
| -66.1873% | |
| -56.4671% | |
| -40.911% | |
| -9.0309% | |
| 24.9808% | |
| 36.4388% | |
| 20.5197% | |
| -52.9418% | |
| -239.5057% | |
| -95.4955% | |
| -29.2616% | |
| 37.7888% | |
| 56.9347% | |
| -349.8384% |